Get the Stockscreener App
1.10
2.65%
-0.03
Cero Therapeutics Holdings Inc Stock (CERO) Forecast
The Cero Therapeutics Holdings Inc (CERO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.25, representing a +286.36% increase from the current price of $1.10. The highest analyst price target is $8.241, and the lowest is $0.259.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CERO Price Target
Average 4.2506
(+286.42% Upside)
Is Cero Therapeutics Holdings Inc (CERO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.06 | Neutral |
| STOCH(9,6) | 10.38 | Buy |
| STOCHRSI(14) | 4.1812 | Buy |
| MACD(12,26) | -0.2086 | Buy |
| ADX(14) | 18.10 | Neutral |
| William %R | -96.84 | Buy |
| CCI(14) | -88.62 | Neutral |
Buy: 4
Sell: 0
Neutral: 3
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.1899
Sell
|
1.1939
Sell
|
| MA20 |
1.2913
Sell
|
1.3286
Sell
|
| MA50 |
1.7943
Sell
|
1.8608
Sell
|
| MA100 |
1.342
Sell
|
0.00
Buy
|
| MA200 |
0.671
Buy
|
0.00
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, CERO could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on CERO, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 30.06 indicates that CERO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.38 indicates that CERO is oversold. This indicates that CERO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.1812 indicates that CERO is oversold. This suggests that CERO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.1 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.62 indicates that CERO is still oversold but not to an extreme extent.
Long-term CERO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cero Therapeutics Holdings Inc financial reports and earnings history, Cero Therapeutics Holdings Inc (CERO) stock could reach $66.35 by 2030, $146.19 by 2040 and $175.02 by 2050. See the projected annual prices until 2050 of the Cero Therapeutics Holdings Inc stock below:
- Cero Therapeutics Holdings Inc (CERO) is expected to reach an average price of $134.62 in 2035, with a high prediction of $133.38 and a low estimate of $44.80. This indicates an $12,138% rise from the last recorded price of $1.10.
- Cero Therapeutics Holdings Inc (CERO) stock is projected to chart a bullish course in 2040, with an average price target of $117.33, representing an $10,566% surge from its current level. The forecast ranges from a conservative $117.37 to a sky-high $146.19.
- Our analysts predict Cero Therapeutics Holdings Inc (CERO) to jump 20,065% by 2045, soaring from $222.07 to an average price of $221.82, potentially reaching $259.18. While $222.07 is the low estimate, the potential upside is significant.
- Cero Therapeutics Holdings Inc (CERO) stock is expected to climb by 2050, reaching an average of $126.01, a $11,355% jump from its current level. However, a wide range of estimates exists, with high and low targets of $175.02 and $126.06, respectively, highlighting the market's uncertainty.
Cero Therapeutics Holdings Inc Stock (CERO) Year by Year Forecast
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2024
Our forecast for CERO stock price in 2024 now indicates an average price target of $5.4815 with a high forecast of $10.95 and a low forecast of $0.0129. The average prediction reflects an increase of +398.31% from the last recorded price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.8792 | $0.259 | $8.241 | -20.07% |
| July, 2024 | $0.0629 | $0.0129 | $1.7419 | -94.28% |
| August, 2024 | $3.154 | $0.2157 | $2.3793 | +186.73% |
| September, 2024 | $2.6671 | $2.7271 | $5.5319 | +142.46% |
| October, 2024 | $1.6296 | $1.6696 | $1.5606 | +48.15% |
| November, 2024 | $6.4618 | $0.9387 | $5.0318 | +487.43% |
| December, 2024 | $5.4588 | $5.6088 | $5.4338 | +396.26% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2025
Cero Therapeutics Holdings Inc Stock (CERO) is expected to reach an average price of $10.02 in 2025, with a high prediction of $17.94 and a low estimate of $2.093. This indicates an +810.63% rise from the last recorded price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.5177 | $3.6077 | $4.3306 | +219.79% |
| February, 2025 | $8.82 | $2.093 | $7.58 | +701.82% |
| March, 2025 | $6.8861 | $8.3861 | $8.4884 | +526.01% |
| April, 2025 | $5.6012 | $5.6512 | $6.6951 | +409.20% |
| May, 2025 | $4.0438 | $3.2473 | $4.8404 | +267.62% |
| June, 2025 | $11.45 | $11.70 | $11.54 | +940.80% |
| July, 2025 | $8.3503 | $8.3903 | $9.2314 | +659.11% |
| August, 2025 | $5.2454 | $5.2954 | $7.0965 | +376.85% |
| September, 2025 | $15.37 | $4.4017 | $14.71 | +1,297% |
| October, 2025 | $10.07 | $11.59 | $13.93 | +815.89% |
| November, 2025 | $7.6289 | $7.6689 | $8.9418 | +593.54% |
| December, 2025 | $18.43 | $5.556 | $17.94 | +1,575% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2026
The predicted value for Cero Therapeutics Holdings Inc (CERO) in 2026 is set at an average of $17.35. Estimates vary from a peak of $27.98 to a trough of $6.7103, indicating an +1,477% surge from the present price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.48 | $14.54 | $16.81 | +1,217% |
| February, 2026 | $10.21 | $10.30 | $12.00 | +828.00% |
| March, 2026 | $22.42 | $6.7103 | $21.18 | +1,938% |
| April, 2026 | $18.14 | $18.29 | $21.17 | +1,549% |
| May, 2026 | $12.98 | $13.03 | $16.15 | +1,080% |
| June, 2026 | $9.6976 | $7.8647 | $11.53 | +781.60% |
| July, 2026 | $20.43 | $21.93 | $24.58 | +1,757% |
| August, 2026 | $16.42 | $16.46 | $19.38 | +1,393% |
| September, 2026 | $11.75 | $9.019 | $14.48 | +968.04% |
| October, 2026 | $25.86 | $26.11 | $27.98 | +2,251% |
| November, 2026 | $18.84 | $20.36 | $21.91 | +1,613% |
| December, 2026 | $11.88 | $11.93 | $16.42 | +980.07% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cero Therapeutics Holdings Inc (CERO) is $25.88, with a high forecast of $41.58 and a low forecast of $10.17. This indicates an +2,252% increase from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.64 | $10.17 | $31.38 | +2,686% |
| February, 2027 | $23.94 | $24.00 | $28.34 | +2,076% |
| March, 2027 | $15.13 | $15.17 | $20.76 | +1,275% |
| April, 2027 | $35.51 | $11.33 | $34.78 | +3,128% |
| May, 2027 | $28.29 | $28.44 | $32.92 | +2,471% |
| June, 2027 | $18.57 | $18.66 | $25.60 | +1,588% |
| July, 2027 | $39.42 | $12.48 | $38.18 | +3,484% |
| August, 2027 | $31.27 | $32.77 | $37.30 | +2,742% |
| September, 2027 | $22.21 | $22.26 | $29.52 | +1,919% |
| October, 2027 | $16.76 | $13.64 | $19.89 | +1,424% |
| November, 2027 | $37.38 | $37.63 | $41.58 | +3,299% |
| December, 2027 | $26.51 | $26.55 | $32.06 | +2,310% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2028
In 2028, Cero Therapeutics Holdings Inc (CERO) is projected to reach an average price of $34.99, with a high projection of $55.18 and a low estimate of $14.79. This indicates an +3,080% rise from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.19 | $17.24 | $23.70 | +1,463% |
| February, 2028 | $42.86 | $14.79 | $44.98 | +3,797% |
| March, 2028 | $29.79 | $31.31 | $39.87 | +2,608% |
| April, 2028 | $21.13 | $21.17 | $26.51 | +1,821% |
| May, 2028 | $45.92 | $15.95 | $48.38 | +4,074% |
| June, 2028 | $35.76 | $35.82 | $42.75 | +3,151% |
| July, 2028 | $25.26 | $25.35 | $31.71 | +2,196% |
| August, 2028 | $51.64 | $17.10 | $51.78 | +4,595% |
| September, 2028 | $40.97 | $41.12 | $48.20 | +3,624% |
| October, 2028 | $29.59 | $29.64 | $37.42 | +2,590% |
| November, 2028 | $56.42 | $18.25 | $55.18 | +5,029% |
| December, 2028 | $44.81 | $46.31 | $53.44 | +3,974% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2029
The 2029 price forecast for Cero Therapeutics Holdings Inc Stock (CERO) is $44.09 on average, with a high prediction of $68.78 and a low estimate of $19.41. This represents an +3,909% increase from the previous price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $31.44 | $31.49 | $42.20 | +2,758% |
| February, 2029 | $23.83 | $19.41 | $28.26 | +2,067% |
| March, 2029 | $51.79 | $52.04 | $58.58 | +4,609% |
| April, 2029 | $38.56 | $40.08 | $44.74 | +3,405% |
| May, 2029 | $23.82 | $23.87 | $34.58 | +2,066% |
| June, 2029 | $58.14 | $20.56 | $61.98 | +5,185% |
| July, 2029 | $45.21 | $45.27 | $54.28 | +4,010% |
| August, 2029 | $28.63 | $28.67 | $40.48 | +2,502% |
| September, 2029 | $64.55 | $21.72 | $65.38 | +5,768% |
| October, 2029 | $47.57 | $47.63 | $60.42 | +4,225% |
| November, 2029 | $33.62 | $33.71 | $42.67 | +2,957% |
| December, 2029 | $70.02 | $22.87 | $68.78 | +6,265% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2030
Cero Therapeutics Holdings Inc Stock (CERO) is expected to reach an average price of $51.50 in 2030, with a high forecast of $78.98 and a low forecast of $24.03. This signifies an +4,582% surge from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $53.65 | $53.80 | $66.35 | +4,777% |
| February, 2030 | $38.82 | $38.87 | $49.24 | +3,429% |
| March, 2030 | $29.49 | $24.03 | $34.95 | +2,581% |
| April, 2030 | $63.32 | $63.57 | $72.18 | +5,656% |
| May, 2030 | $44.68 | $44.72 | $54.88 | +3,961% |
| June, 2030 | $29.13 | $29.18 | $40.31 | +2,548% |
| July, 2030 | $66.20 | $25.18 | $75.58 | +5,918% |
| August, 2030 | $49.51 | $51.03 | $57.42 | +4,401% |
| September, 2030 | $34.63 | $34.67 | $44.67 | +3,048% |
| October, 2030 | $73.41 | $26.33 | $78.98 | +6,573% |
| November, 2030 | $57.03 | $57.09 | $68.68 | +5,084% |
| December, 2030 | $40.31 | $40.40 | $51.43 | +3,565% |
0.77%
1.20%
Cap:
|
Volume (24h):